Skip to main content
. 2022 Dec 15;16(1):11–28. doi: 10.1159/000528083

Table 3.

Latest evidence in MNT for adult obesity from RCTs and systematic reviews/meta-analyses

First author Year Population Intervention Duration Main outcome Evidence level Conclusion
RCTs
Ghanwat and Sontakke [23]
2019 Adults with WC ≥80/90 cm Vitamin C 500 mg 3/d 3 months FBG, insulin, HOMA-IR, and QUICKI Level 2 Improvement in FBG, insulin, HOMA-IR, and QUICKI

Romain et al. [24] 2021 Adults with BMI 25–40 kg/m2 Flavonoid and vitamin B3-rich extract versus placebo 16 weeks BW, WC, BF, health-related QoL Level 2 Improvements in BW, WC, and BF, physical health QoL

Rohling et al. [41] 2021 Adults with BMI 27–35 kg/m2 and w/> 1 component of metabolic syndrome Meal replacement by formula diet versus lifestyle 52 weeks BW Level 2 12 weeks: meal replacement linked to larger BW (-2.39 kg)
52 weeks: no difference

Halle [42] 2020 Adults with BMI 27–35 kg/m2 and w/> 1 component of metabolic syndrome Meal replacement by formula diet versus lifestyle 52 weeks FM, FFM, WC, FBG, SBP, DBP, TC, HDL-c, LDL-c, TG Level 2 Improvements in all parameters

Lowe et al. [53] 2020 Adults with BMI 27–43 kg/m2 Time-restricted eating (16:8 h) 12 weeks BW, FM, LM, insulin, FBG, HbA1c Level 2 No evidence of difference

Hassapidou et al. [31] 2020 Adults with BMI ≥25 kg/m2 MED versus usual care 6 months BW, WC, HC, % BF Level 2 Weight loss only in the intervention group

Headland et al. [51] 2019 Adults with BMI ≥25 kg/m2 IF versus CER 12 months BW, body composition, TC, HDL-c, LDL-c, TG, FBG Level 2 No difference in any parameter

Brown et al. [45] 2020 Adults with T2DM (insulin) and obesity Low-energy total meal replacement 12 months BW, HbA1c, FBG, C-peptide, serum lipids, BP, body composition, and QoL Level 2 Improved BW, HbA1c, insulin dosage, QoL

Gajewska [81] 2019 Adults with BMI ≥25 kg/m2 and hypertension Nutrition education individual versus group 6 months BW, WC, BP, FBG, OGTT, HOMA-IR, lipids Level 2 Better BW, WC, BP, OGTT, HOMA-IR with individual education

Sundfør et al. [52] 2019 Adults with BMI 30–45 kg/m2 and w/> 1 component of metabolic syndrome IER versus CER 3 months BW, energy intake Level 2 No differences in BW Better dietary habits with CER

Cai et al. [32] 2019 Adults >60 y with BMI ≥28 kg/m2 Community intervention versus usual care 24 months BW, WC, BP, FBG, TC, HDL-c, LDL-c, TG Level 2 Community intervention linked to improved BW, WC, SBP, TG, HDL-c

Gepner et al. [35] 2019 Adults with WC ≥88/102 cm or TG≥150 mg/dL and HDL-c <40 mg/dL/<50 mg/dL MED versus low-fat diet 18 months BW, WC, FBG, insulin, TC, LDL-c, HDL-c, TG, HOMA-IR, hepatic fat content Level 2 MED reduced hepatic fat content, TG, HDL-c, DBP further than low-fat diet

Mitra [82] 2019 Adults with BMI ≥23 kg/m2 High-protein, vit E, and fibre, energy-restricted diet versus usual care 6 months BW, WC, HC, FM, FFM, TC, TG, HDL-c, FBG, insulin, CRP, HOMA-IR Level 2 The intervention led to significant improvements in BW, WC, FM, insulin, HOMA-IR, CRP

Otten [83] 2019 Postmenopausal women with BMI 27–41 kg/m2 Paleolithic dietary pattern versus Nordic diet 2 years BW, FM, OGTT, Glucagon, GLP-1, GIP 1A large Paleolithic diet superior to Nordic in BW, FM, and GLP-1

Salas-Salvado et al. [36] 2019 Adults with BMI 27–40 kg/m2 and metabolic syndrome MED and physical activity weight loss intervention versus MED alone 12 months BW, WC, FM, FFM, FBG, HOMA-IR, DBP, SBP, HbA1c, TG, TC, HDL-c, CRP, IL, TNF-α 1A large Intensive MED intervention led to further improvements in BW, WC, insulin, FBG, HOMA-IR, blood lipids

Ilich et al. [25] 2019 Postmenopausal women with 26–45 kg/m2 Calcium (1.5 g/d) and vitamin D (600 IU/d) via foods or supplements 6 months BW, WC, HC, FM, LM, BMD Level 2 Calcium and vitamin D supplementation through food associated with better BW and FM

Weaver [84] 2019 Adults >65 y with BMI ≥30 kg/m2 Hypocaloric diet with 1 g/kg BW protein versus normocaloric 0.8 g/kg BW protein 6 months BW, BMD 1A large BW changes only in intervention without differences in bone density

Higgins [85] 2019 Adults with BMI ≥25 kg/m2 Sucrose, aspartame, saccharin, sucralose, rebaudioside A 12 weeks BW, FM, FFM, OGTT Level 2 Sucrose and saccharin led to increased BW Sucralose associated with BW reduction No impact on OGTT

Phelan et al. [44] 2018 Women at 9–16 weeks gestation with pregestation BMI ≥25 kg/m2 Partial meal replacement versus usual care 26 weeks Gestational weight gain Level 2 Partial meal replacement linked with better adherence to gestational weight gain guidelines

Guo et al. [43] 2018 Adults with BMI >24 kg/m2 Meal replacement versus routine diet 12 weeks BW, WC, HC, FFM, FM, SBP, DBP, TC, TG, HDL-c, FBG Level 2 Meal replacements were associated with greater improvements in BW, WC, FFM, FM, and FBG

Watson [86] 2018 Adults with BMI ≥25 kg/m2 and T2DM High-protein versus high-carbohydrate dietary patterns 24 weeks BW, WC Psychological wellbeing, QoL, sleep Level 2 High-protein diets expand the positive impact of weight loss on general health and vitality

Madjd [87] 2018 Adult women with overweight or obesity Replacing low-calorie sweetened beverages with water Weight loss, BMI, HOMA-IR, 2-h postprandial glucose Level 2 Replacement of low-calorie sweetened beverages with water after the main meal in women who were regular users of low-calorie sweetened beverages may cause further weight reduction during a 12-month weight maintenance programme. It may also offer benefits in carbohydrate metabolism including improvement of insulin resistance over the long-term weight maintenance period

Gorostegi-Anduaga [88] 2018 Adults with overweight and obesity with primary hypertension and are sedentary Aerobic exercise and nutritional intervention Cardiovascular risk scores and vascular age Level 2 The improvement in CVR factors after 16-week lifestyle changes reduced the risk of suffering a cardiovascular event in adults with overweight/obesity with HTN through the FRS estimation tool but not with the ASCVD score. The risk score algorithms could underestimate CVR in women. In contrast, VA could be a useful and easier tool in the management of individuals with CVRfactors

Kahleova [89] 2018 Adults with overweight or obesity Plant-based high-carbohydrate, low-fat (vegan) dietary pattern or to maintain their current dietary pattern A linear regression model was used to test the relationship between carbohydrate intake and body composition and insulin resistance 1A large Results suggest encouraging a flexible approach to eating behaviour and discouraging rigid adherence to a dietary pattern may lead to better intentional weight loss for older women with overweight and obesity

Berg [90] 2018 Older women with overweight or obesity Flexible eating behaviour following a diet and exercise intervention Weight loss Level 2

Dus-Zuchowska et al. [37] 2018 Postmenopausal women with obesity and a high risk of metabolic syndrome CED could be an alternative to the MED CRP and asymmetrical dimethylarginine Level 2 In the central European postmenopausal women with obesity population, a well-designed, energy-restricted diet with the use of food items traditional for the region (CED) could be a good alternative to MED in terms of AT prevention

Kikuchi [91] 2018 Japanese adults with visceral fat obesity Refined wheat bread versus whole grain wheat bread BW, BMI, WC, VFA, lipids, BP, diabetes measures Level 2 The WW group showed decrease (–4 cm2) in VFA (p < 0.05), whereas the RW group showed no significant changes. These time-dependent changes were significantly different between the groups. WW diet led to significant and safe reductions in VFA in subjects with BMI ≥23 kg/m2. WW diet may contribute to preventing visceral fat obesity

Höchsmann et al. [33] 2021 Adults with obesity Primary care: ILI FBG and lipids, SBP, DBP, metabolic syndrome severity Level 2 A pragmatic ILI consistent with national guidelines and delivered by trained health coaches in primary care produced clinically relevant improvements in cardiometabolic health in an underserved population over 24 months

Miller et al. [29] 2021 Adults 50–75 years old BMI ≥25 kg/m2 with T2DM Whey protein (40 g/d) + vit D3 (2000 IU/d) combined with exercise versus exercise alone (n = 198) 24 weeks HbA1c, HOMA2-IR, FBG Body composition, BP, lipid profile, inflammatory markers Level 2 No effect on body composition, HbA1c, HOMA2-IR Improved FBG

Haghighat [92] 2020 Women with BMI between 18.5 and 24.9 kg/m2 and an excess in BF% >33.3% Euengetic high protein versus standard protein Appetite and body composition 1A large

Aparecida Silveira [93] 2020 Adults with sarcopenia and severe obesity EVOO and/or the traditional Brazilian diet Level 2 DieTBra contributes to improvements in handgrip strength, walking speed, and total BF in adults with obesity (BMI >40 kg/m2)

Lison [94] 2020 Patients with obesity and hypertension Web-based exercise and nutritional education BMI (primary outcome), FM, SBP, DBP, FBG, insulin, physical activity levels, and functional capacity for aerobic exercise Level 2

Rakvaag et al. [30] 2019 Adults with abdominal obesity (n = 65) Whey protein (60 g/d) combined with wheat bran (30 g/d) 12 weeks Fasting and postprandial lipid profiles 1A large Whey protein increased fasting TC with or without wheat bran
Whey protein improved TG only without wheat bran

Yari [95] 2020 Adults with overweight or obesity Flaxseed Anthropometric measurements, lipid profile, HOMA-IR, and inflammatory biomarkers Level 2

Meta-analysis or systematic review of high-quality RCT
Qu et al. [28] 2021 Adults
BMI ≥25 kg/m2
Prebiotics supplements versus Placebo BMI, BW, WC CRP, TN-a, IL-1β, LPS Level 1a (meta-analysis) No difference in adiposity parameters Improvements in inflammatory markets

Enriquez Guerrero [96] 2021 Adult population (18–70 years old) with BMI ≥25 kg/ m2 IF versus CER BMI, BW, WC, FM TC, HDL-c, LDL-c, TG Level 1a (meta-analysis) IF showed higher weight loss and higher FM reduction but similar WC reduction IF improved lipid profile, but evidence is less conclusive

Willems [97] 2021 Adults with obesity Low-carbohydrate and low-fat dietary patterns Markers of the metabolic syndrome Level 2 Higher fat and protein intakes associated with improved markers of MetS

Park et al. [46] 2020 Adults
BMI ≥25 kg/m2
ADF BMI, BW, WC, FM, and LM TC, TG, HDL-c, LDL-c, FBG, insulin, HOMA-IR, CRP, SBP, and DBP Level 1a ADF effectively lowers BMI, BW, FM, and TC in adults with BMI ≥25–29.9 kg/m2 in interventions <6 months compared to control ADF lowers WC in adults with BMI ≥30 kg/m2, ≥40 years old

Yan et al. [47] 2020 Adults with overweight or obesity Fasting BW, BMI, FFM, FM, WC, TC, LDL-c, HDL-c, TG, SBP, DBP, FBG, insulin Level 1a Our meta-analysis found that fasting was associated with a significant effect on the regulation of anthropometric (BW, BMI, FEM, FM, and WC) and metabolic parameters (LDL-C, TG, SBP, and DBP) in people with overweight or obesity

Maula et al. [39] 2020 Adults with overweight or obesity and type 2 diabetes Educational weight loss interventions BW and BMI change Level 1a Low-calorie, low-carbohydrate meal replacements or dietary patterns combined with education appear the most promising interventions to achieve the largest weight and BMI reductions in people with type 2 diabetes

Wang [98] 2020 Adults with overweight or obesity Whole grain foods Cardiovascular risk outcomes Level 1a This study suggests that whole grain food consumption can slightly reduce BW and CRP in people with overweight/obesity

Mu [99] 2019 Asian women (non-menopausal) with overweight or obesity Soy products BW, BMI, % BF, FM, WC Level 1a This meta-analysis showed that soy products have weight loss effects, mainly due to soy protein, isoflavone, and soy fibre

Suzumura et al. [27] 2019 Adults with overweight or obesity Oral supplementation with probiotics or symbiotics BW, BMI, WC Level 1a oral supplementation with probiotics or symbiotics has a small effect on WC reduction but no effect on BW or BMI Low to moderate quality of evidence

Roman et al. [50] 2019 Adults with overweight or obesity Intermittent versus continuous fasting BW, BF, LM, WC, HC, and energy expenditure (kJ/day) Level 1a This systematic review in individuals with overweight and obesity showed that regular IF decreased LM compared to continuous fasting. There were no differences in effects for either intermittent versus continuous interventions across all other outcomes

Bassatne et al. [26] 2019 Adults with obesity Vitamin D supplementation BMD, extra-skeletal parameters Level 2 No clear evidence for a beneficial effect of vitamin D supplementation on cardiometabolic parameters in adults living with obesity

Gjuladin-Hellon [100] 2019 Adults BMI ≥25 kg/m2 Very low- and low-carbohydrate dietary patterns versus low-fat dietary patterns TC, TG, HDL-c, LDL-c Level 1a (meta-analysis) Carbohydrate restriction is superior to fat restriction in improving lipid profile

Astbury et al. [40] 2019 Adults with overweight or obesity Meal replacements Weight loss Level 1a Programmes incorporating meal replacements led to greater weight loss at 1 year than comparator weight loss programmes and should be considered as a valid option for management of overweight and obesity in community and healthcare settings

Booth [101] 2018 Adults with overweight or obesity Diet-induced weight loss Psychological stress Level 1a

Castellana [102] 2020 Adults with overweight or obesity VLCKD BW, BMI, WC, body composition, BP, HbA1c, lipids, and markers of liver and kidney function Level 1a VLCKD proved to be a reliable option to achieve a significant weight loss in patients with overweight and obesity. Results were early obtained during the ketogenic phase and were stable over a follow-up of up to two years. In addition, VLCKD was associated with significant improvements in comorbidities, including hypertension, dyslipidaemia, T2DM, and NAFLD. However, an increase in serum sodium was found. VLCKD should thus be regarded as an effective intervention to be proposed to properly selected patients, as a part of a multicomponent strategy, and under strict medical supervision

Noronha et al. [38] 2019 Adults with overweight or obesity and T2D Liquid meal replacements Cardiometabolic risk factors Level 1a Liquid meal replacements in weight loss diets lead to modest reductions in BW, BMI, and SBP and reductions of marginal clinical significance in BF, WC, HbA1c, fasting glucose, fasting insulin, and DBP

Cheng [103] 2018 Postmenopausal women with obesity Nutrition and exercise interventions BW, BMI, WC, FM, LM Level 1a (meta-analysis) Diet and exercise combined results in greater weight loss, FM, and LM loss Diet alone leads to greater weight loss than exercise alone

Jovanovski [104] 2021 Adults BMI ≥25 kg/m2 Viscous fibre supplementation in calorie-restricted dietary pattern BW, BMI, WC, BF Level 1a (meta-analysis) Moderate evidence for reduced BW, BMI, and BF
Low evidence for reduced WC

Vitale and Kim [49] 2020 Adults with obesity and T2DM IF BW and glycaemic control Level 1a (systematic review) Insignificant differences between IF and CER on glycated haemoglobin A1c and body composition

Canuto et al. [34] 2021 Adults with overweight and obesity Primary care interventions Weight reduction Level 3 (meta-analysis) No impact of diet alone or combined approaches on weight loss Similar findings for individual versus group sessions

Churuangsuk [105] 2018 Adults with overweight or obesity Low-carb dietary patterns Weight loss Level 3 (review of reviews) Little or no difference in weight loss with low-carb dietary patterns versus control

TD2M, type 2 diabetes mellitus; BMI, body mass index; WC, waist circumference; HC, hip circumference; BF, body fat; BW, body weight; FM, fat mass; LM, lean mass; FFM, fat free mass; TC, total cholesterol; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; TG, triglyceride; CRP, C-reactive protein; TN-a, tumour necrosis factor alpha; IL-1β, interleukin 1β; LPS, lipopolysaccharide; BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; HOMA-IR, homeostatic model assessment for insulin resistance; HbA1c, glycated haemoglobin; OGTT, oral glucose tolerance test; BMD, bone mineral density; ILI, intensive lifestyle intervention; EVOO, extra virgin olive oil; IER, intermittent energy restriction; CED, Central European diet; VFA, visceral fat area. ADF, alternate day fasting; VLCKD, very low-calorie ketogenic diet.